NCT06987669Not yet recruiting
Gastric Emptying in Healthy Volunteers and GLP-1 Agonist Users
Gastric Emptying Assessed by Gastric Ultrasound (US) in Healthy Volunteers and Semaglutide Users: Cohort Study
Source: ClinicalTrials.gov · Last updated 23 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This observational study aims to determine the gastric emptying kinetics assessed by ultrasound in healthy volunteers after a standard breakfast and the state of the stomach after a clear liquid diet for 18 /24 hours in patients on GLP-1 agonist. The main questions it seeks to answer are: * Is the kinetic after a standard breakfast that includes ( avocado and eggs: high fat) as fast as a standard meal that does not involve this food? * Is a clear liquid diet of 18 to 24 hours enough to be an empty-stomach, assessed by Ultrasound in patients on GLP1 agonist? Participants will be asked to do: -A baseline Gastric US will be performed for healthy volunteers, and then they will have a standardized breakfast. An hourly or bihourly assessment will be done by the US.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 155 (estimated)
- First submitted
- 8 May 2025
- Start date
- 17 May 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Clinica Alemana de Santiago
- Diseases
- Obesity, Type 2 diabetes
- NCT number
- NCT06987669
What you commit to
- Study type: Observational
- Planned participants: 155
- From 17 May 2025 to the primary completion date, 31 Dec 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Bariatric surgery
Other illness
- Impairment to give consent
Other
- Hiatal hernia
Who the study is looking for
- 18 years old or older
- Healthy volunteers or semaglutide users
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.